Send feedback

APOL5

gene
On this page

Also known as APOLV

Summary

APOL5 (apolipoprotein L5, HGNC:14869) is a protein-coding gene on chromosome 22q12.3, encoding Apolipoprotein L5 (Q9BWW9). May affect the movement of lipids in the cytoplasm or allow the binding of lipids to organelles.

This gene is a member of the apolipoprotein L gene family. The encoded protein is found in the cytoplasm, where it may affect the movement of lipids or allow the binding of lipids to organelles.

Source: NCBI Gene 80831 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 81 total
  • GTEx eGene: eQTL in 9 tissues, sQTL in 0 (q < 0.05)
  • Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.09 (unconstrained)
  • MANE Select transcript: NM_030642
  • Notable: 81 clinical variants but no curated precision-oncology (CIViC) evidence yet

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:14869
Approved symbolAPOL5
Nameapolipoprotein L5
Location22q12.3
Locus typegene with protein product
StatusApproved
AliasesAPOLV
Ensembl geneENSG00000128313
Ensembl biotypeprotein_coding
OMIM607255
Entrez80831

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

MANE Select: ENST00000249044

Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1

ENST00000249044

RefSeq mRNA: 1 — MANE Select: NM_030642 NM_030642

CCDS: CCDS13920

Canonical transcript exons

ENST00000249044 — 5 exons

ExonStartEnd
ENSE000008800213572621135727194
ENSE000008800223572872335728904
ENSE000009112443571787235717926
ENSE000009360343572935435729483
ENSE000012757373572056835720654

Expression profiles

Bgee: expression breadth broad, 36 present calls, max score 84.33.

Highest expression (Bgee): male germ line stem cell (sensu Vertebrata) in testis, primordial germ cell in gonad, hindlimb stylopod muscle, skeletal muscle tissue, muscle of leg.

Genetic regulation across tissues (GTEx eQTL / sQTL)

APOL5 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 9 tissues and its splicing (sQTL) in 0 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.

9 significant tissue × QTL associations:

TissueQTLq-valueSlopeLead variant
Muscle Skeletaleqtl2.0e-64-0.5522:35685923:A:C
Livereqtl2.5e-23+0.7522:35726883:C:T
Adipose Subcutaneouseqtl8.6e-23-0.4722:35646939:C:T
Nerve Tibialeqtl7.9e-17-0.4822:35646939:C:T
Breast Mammary Tissueeqtl2.9e-10-0.4022:35646939:C:T
Adipose Visceral Omentumeqtl3.0e-07-0.3622:35646939:C:T
Thyroideqtl3.9e-06-0.3022:35646939:C:T
Heart Left Ventricleeqtl3.5e-04-0.3122:35642029:C:T
Artery Coronaryeqtl1.6e-03-0.3722:35646939:C:T

Top tissues by expression

99 tissues by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.33silver quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099179.37silver quality
hindlimb stylopod muscleUBERON:000425259.00gold quality
skeletal muscle tissueUBERON:000113457.41gold quality
muscle of legUBERON:000138353.23gold quality
gastrocnemiusUBERON:000138850.61gold quality
muscle tissueUBERON:000238550.05gold quality
right lobe of liverUBERON:000111447.75gold quality
lower esophagus mucosaUBERON:003583446.69silver quality
liverUBERON:000210746.66gold quality
gall bladderUBERON:000211044.48gold quality
apex of heartUBERON:000209842.11silver quality
prefrontal cortexUBERON:000045140.60gold quality
heart left ventricleUBERON:000208439.53gold quality
left testisUBERON:000453339.30gold quality
testisUBERON:000047338.78gold quality
subcutaneous adipose tissueUBERON:000219038.61silver quality
primary visual cortexUBERON:000243638.45silver quality
anterior cingulate cortexUBERON:000983537.98silver quality
thoracic mammary glandUBERON:000520037.75gold quality
frontal cortexUBERON:000187037.67gold quality
ganglionic eminenceUBERON:000402337.36gold quality
colonic epitheliumUBERON:000039737.20gold quality
right testisUBERON:000453437.14gold quality
heartUBERON:000094837.01gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
dorsolateral prefrontal cortexUBERON:000983436.24silver quality
bone marrow cellCL:000209236.16gold quality
mucosa of stomachUBERON:000119936.03silver quality
Brodmann (1909) area 9UBERON:001354035.91silver quality
adipose tissueUBERON:000101335.90silver quality
cerebral cortexUBERON:000095635.87gold quality
right coronary arteryUBERON:000162535.62gold quality
mucosa of transverse colonUBERON:000499135.09gold quality
duodenumUBERON:000211432.80gold quality
left coronary arteryUBERON:000162631.86gold quality
bone marrowUBERON:000237131.74gold quality
lymph nodeUBERON:000002931.47gold quality
descending thoracic aortaUBERON:000234531.31gold quality
superior frontal gyrusUBERON:000266131.10gold quality
material anatomical entityUBERON:000046530.76gold quality
multicellular organismUBERON:000046830.76gold quality
brainUBERON:000095530.31gold quality
adrenal tissueUBERON:001830330.24gold quality
tonsilUBERON:000237230.06gold quality
vermiform appendixUBERON:000115430.02silver quality
rectumUBERON:000105229.92gold quality
tibial arteryUBERON:000761029.88silver quality
stromal cell of endometriumCL:000225529.87gold quality
popliteal arteryUBERON:000225029.78silver quality
cortex of kidneyUBERON:000122528.93silver quality
temporal lobeUBERON:000187128.77silver quality
bloodUBERON:000017828.52gold quality
smooth muscle tissueUBERON:000113528.45silver quality
amygdalaUBERON:000187628.39silver quality
islet of LangerhansUBERON:000000628.37gold quality
endometriumUBERON:000129527.73gold quality
muscle layer of sigmoid colonUBERON:003580527.38gold quality
fallopian tubeUBERON:000388926.91gold quality
kidneyUBERON:000211326.68gold quality
small intestineUBERON:000210826.56gold quality
left uterine tubeUBERON:000130326.55gold quality
pancreasUBERON:000126426.50gold quality
leukocyteCL:000073826.48gold quality
monocyteCL:000057626.37gold quality
olfactory segment of nasal mucosaUBERON:000538625.89gold quality
placentaUBERON:000198725.82gold quality
ovaryUBERON:000099225.56gold quality
small intestine Peyer’s patchUBERON:000345425.49gold quality
right ovaryUBERON:000211825.06gold quality
nucleus accumbensUBERON:000188224.86gold quality
lungUBERON:000204824.71gold quality
left ovaryUBERON:000211924.61gold quality
body of stomachUBERON:000116124.52gold quality
skin of legUBERON:000151124.49gold quality
right lungUBERON:000216724.49gold quality
body of pancreasUBERON:000115024.27gold quality
zone of skinUBERON:000001424.09gold quality
vaginaUBERON:000099623.66gold quality
prostate glandUBERON:000236723.37gold quality
corpus callosumUBERON:000233623.36gold quality
skin of abdomenUBERON:000141623.25gold quality
adrenal glandUBERON:000236923.14gold quality
transverse colonUBERON:000115723.10gold quality
body of uterusUBERON:000985323.05gold quality
right adrenal glandUBERON:000123322.82gold quality
adult mammalian kidneyUBERON:000008222.52gold quality
ectocervixUBERON:001224922.22gold quality
C1 segment of cervical spinal cordUBERON:000646921.93gold quality
left adrenal glandUBERON:000123421.59gold quality
right adrenal gland cortexUBERON:003582721.50gold quality
upper lobe of left lungUBERON:000895221.43gold quality
spleenUBERON:000210621.11gold quality
granulocyteCL:000009420.63gold quality
left adrenal gland cortexUBERON:003582519.74gold quality
adenohypophysisUBERON:000219619.40gold quality
right uterine tubeUBERON:000130216.49gold quality
metanephros cortexUBERON:001053315.43gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.66

HPA expression

RNA tissue specificity: Tissue enhanced

18 HPA tissues / cells by nTPM:

Tissue / cellAxisnTPM
Tonguetissue1.9
Skeletal muscletissue1.3
Cerebral cortextissue0.4
Hippocampal formationtissue0.3
Testistissue0.2
Heart muscletissue0.2
Amygdalatissue0.2
Cerebellumtissue0.2
Ponstissue0.1
Adipose tissuetissue0.1
Basal gangliatissue0.1
Medulla oblongatatissue0.1
Hypothalamustissue0.1
Gallbladdertissue0.1
Hippocampustissue0.1
Postcentral gyrustissue0.1
Retrosplenial cortextissue0.1
Occipital cortextissue0.1

Brain sub-regions (HPA Brain Atlas): detected in 68; highest nTPM — Parieto-insular cortex (0.4), Hippocampus, CA3 (0.3), Posterior insular cortex (0.3), Angular gyrus (white matter) (0.2), Anterior insular cortex, ventral (0.2).

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

Targeting APOL5 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).

8 miRNAs:

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3064-3P100.0070.091254
HSA-MIR-1212199.9966.64255
HSA-MIR-4715-3P99.9866.03670
HSA-MIR-361-3P99.1966.451381
HSA-MIR-431798.4967.09987
HSA-MIR-1912-5P97.9467.98832
HSA-MIR-3152-5P96.9866.88819
HSA-MIR-1212896.6766.981471

Functional genomics

gnomAD constraint: pLI 4.32e-08, LOEUF 1.09, missense Z 0.586 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD

Regional missense constraint (gnomAD)

ENST00000249044 splits into 3 regions with different missense tolerance; 0 are missense-constrained. Missense variants in a constrained region (low observed/expected) are more likely to be pathogenic. gnomAD

Region (GRCh38)Missense obs / expo/eConstrained
22:35,717,872–35,726,712254 / 254.71.00no
22:35,726,713–35,726,82522 / 46.60.47no
22:35,726,826–35,728,895238 / 229.11.04no

Literature-anchored findings (GeneRIF, showing 1)

  • APOL5 has been found only in humans (PMID:11374903)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
caenorhabditis_elegansWBGENE00017219
caenorhabditis_elegansWBGENE00017220

Paralogs (6): APOL4 (ENSG00000100336), APOL1 (ENSG00000100342), APOL3 (ENSG00000128284), APOL2 (ENSG00000128335), APOLD1 (ENSG00000178878), APOL6 (ENSG00000221963)

Genomic neighbors (locus context)

Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).

SymbolTypeEntrez
RBFOX2protein-coding23543
APOL3protein-coding80833
MBprotein-coding4151
APOL6protein-coding80830

Protein

Protein identifiers

Apolipoprotein L5 — Q9BWW9 (reviewed: Q9BWW9)

Alternative names: Apolipoprotein L-V

All UniProt accessions (1): Q9BWW9

UniProt curated annotations — full annotation on UniProt →

Function. May affect the movement of lipids in the cytoplasm or allow the binding of lipids to organelles.

Subcellular location. Cytoplasm.

Tissue specificity. Low level of expression; detected in uterus, testis, skeletal muscle and stomach.

Similarity. Belongs to the apolipoprotein L family.

RefSeq proteins (1): NP_085145* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR008405ApoLFamily

Pfam: PF05461

UniProt features (8 total): sequence variant 4, compositionally biased region 2, chain 1, region of interest 1

Structure

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BWW9-F141.660.00

Human Protein Atlas

Protein class: Predicted intracellular proteins, Plasma proteins, UniProt - Evidence at transcript level

Protein evidence: Evidence at transcript level

Function

Pathways and Gene Ontology

Reactome pathways

0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).

MSigDB gene sets: 22 (showing top): GOBP_LIPOPROTEIN_METABOLIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_LIPID_LOCALIZATION, GOMF_PROTEIN_LIPID_COMPLEX_BINDING, GOMF_LIPID_BINDING, GOMF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_BINDING, GOMF_PROTEIN_CONTAINING_COMPLEX_BINDING, ZNF22_TARGET_GENES, MIR4317, chr22q12, DESCARTES_MAIN_FETAL_SMOOTH_MUSCLE_CELLS, DESCARTES_FETAL_HEART_SMOOTH_MUSCLE_CELLS, NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_UP, GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN

GO Biological Process (3): lipid metabolic process (GO:0006629), lipid transport (GO:0006869), lipoprotein metabolic process (GO:0042157)

GO Molecular Function (2): high-density lipoprotein particle binding (GO:0008035), lipid binding (GO:0008289)

GO Cellular Component (3): extracellular region (GO:0005576), cytoplasm (GO:0005737), membrane (GO:0016020)

GO top-level categories

8 GO namespaces:

CategoryTerms
cellular anatomical structure3
primary metabolic process1
transport1
lipid localization1
protein metabolic process1
lipoprotein particle binding1
binding1
intracellular anatomical structure1

Protein interactions and networks

STRING

showing 15 of 290 interactions by confidence (×1000):

Protein AProtein BPartner UniProtScore
APOL5COMTP21964671
APOL5CIMIP2CA6NJV1496
APOL5APOOQ9BUR5470
APOL5HPRP00739468
APOL5APOC4P55056401
APOL5APOLD1Q96LR9391
APOL5OR10H5Q8NGA6387
APOL5APOL1O14791363
APOL5APOFQ13790357
APOL5APOL4Q9BPW4351
APOL5APOMO95445323
APOL5NPIPB9F8W1W9322
APOL5NT5DC4Q86YG4309
APOL5ZNF441Q8N8Z8297
APOL5HPP00737293

IntAct

Human interaction partners of APOL5 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).

8 partners by confidence:

PartnerInteraction typeMIscoreRecords
ABL1physical association0.4001
CLTCL1physical association0.4001
CRKphysical association0.4001
FYNphysical association0.4001
GRB2physical association0.4001
NCK1physical association0.4001
PIK3R1physical association0.4001
SRCphysical association0.4001

BioGRID (2 interactions; top human partners by supporting records): CLTCL1 (Affinity Capture-MS), CUL3 (Affinity Capture-MS)

Disease & clinical

Genetic variants

Variant evidence for APOL5: 81 ClinVar records (0 pathogenic / likely pathogenic); 3 GWAS associations.

ClinVar

81 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance69
Likely benign6
Benign2

SpliceAI

Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 14 predictions of 364):

Position(s)EffectΔscoreSites
22:35717927–35717928donor_loss0.98005
22:35720461acceptor_gain0.9700
22:35726397acceptor_gain0.9500
22:35726395acceptor_gain0.9100
22:35726307acceptor_gain0.8700
22:35728754acceptor_gain0.8000
22:35720469acceptor_gain0.7900
22:35720473acceptor_gain0.7900
22:35727129donor_gain0.7900
22:35729346acceptor_gain0.7700

AlphaMissense

112 missense substitutions predicted likely pathogenic (of 2,813 scored), across 62 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:

ResidueLikely-pathogenic substitutionsMean am_pathogenicityMax am_pathogenicity
F10650.7860.877
M15150.6700.676
F25540.8000.869
G17340.6120.691
G17540.6050.645
S16630.8460.846
F10230.8240.824
F28030.8150.815
F27030.8020.802
F26230.7960.796
F11130.7300.730
F30130.7210.721
F21530.7060.706
S14230.6590.659
F7930.5810.581
R33020.7330.733
A12420.7220.769
K11020.7120.712
A14120.7100.720
R19920.6950.695

HPA cancer prognostics

RNA cancer specificity: Not detected

Disease associations

OMIM: gene MIM:607255 | disease phenotypes:

GWAS associations

3 associations:

StudyTraitp-value
GCST005958_5Waist-to-hip ratio adjusted for BMI (age >50)1e-6
GCST002301_5Body mass index3e-6
GCST005962_58Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)6e-6

EFO canonical traits (from GWAS)

4 canonical traits:

EFO IDTrait name
EFO:0004340body mass index
EFO:0007788BMI-adjusted waist-hip ratio
EFO:0008007age at assessment
EFO:0008343sex interaction measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (CPIC guideline: no)

CTD chemical–gene interactions

7 total (human), top 7 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
3,4,5,3’,4’-pentachlorobiphenyldecreases expression1
Resveratrolaffects cotreatment, decreases expression1
Benzo(a)pyreneincreases methylation1
Cadmiumdecreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Rotenoneincreases expression1

Clinical trials (associated diseases)

Via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.